Puissance Cross-Border Opportunities III LLC 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-05-22 06:46 am Purchase |
2020-04-17 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Cross-Border Opportunities III LLC | 53,327 0.900% |
53,327 (New Position) |
Filing |